EWTX EBITDA Growth
Edgewise Therapeutics Inc · EBITDA Growth
EWTX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-31.37%period ending
EWTX TTM EBITDA YoY % (-150.39% → -31.37%)
Year-over-year change
High-resolution chart · PNG
EWTX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -31.37% | |
| -20.8261% | |
| -25.8556% | |
| -26.8804% | |
| -30.3746% | |
| -38.4265% | |
| -33.5869% | |
| -38.4856% | |
| -41.7313% | |
| -38.1715% | |
| -46.7244% | |
| -45.9808% | |
| -43.4968% | |
| -49.3226% | |
| -57.5793% | |
| -66.5711% | |
| -107.4721% | |
| -144.6324% | |
| -150.3851% |